nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—Alzheimer's disease	0.361	1	CbGaD
Droperidol—HTR2A—Donepezil—Alzheimer's disease	0.249	0.556	CbGbCtD
Droperidol—DRD2—Memantine—Alzheimer's disease	0.199	0.444	CbGbCtD
Droperidol—HTR2A—choroid plexus—Alzheimer's disease	0.0118	0.21	CbGeAlD
Droperidol—HTR2A—locus ceruleus—Alzheimer's disease	0.00732	0.13	CbGeAlD
Droperidol—HTR2A—cerebellar cortex—Alzheimer's disease	0.00597	0.106	CbGeAlD
Droperidol—DRD2—telencephalic ventricle—Alzheimer's disease	0.00526	0.0935	CbGeAlD
Droperidol—Tardive dyskinesia—Memantine—Alzheimer's disease	0.00457	0.0459	CcSEcCtD
Droperidol—Dysphoria—Donepezil—Alzheimer's disease	0.00434	0.0435	CcSEcCtD
Droperidol—Altered state of consciousness—Memantine—Alzheimer's disease	0.00369	0.037	CcSEcCtD
Droperidol—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00367	0.0368	CcSEcCtD
Droperidol—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00347	0.0616	CbGeAlD
Droperidol—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00333	0.0334	CcSEcCtD
Droperidol—Sudden death—Memantine—Alzheimer's disease	0.00333	0.0334	CcSEcCtD
Droperidol—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00326	0.0327	CcSEcCtD
Droperidol—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00321	0.0322	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Memantine—Alzheimer's disease	0.00293	0.0294	CcSEcCtD
Droperidol—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.00249	0.025	CcSEcCtD
Droperidol—Torsade de pointes—Memantine—Alzheimer's disease	0.00243	0.0244	CcSEcCtD
Droperidol—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00242	0.0243	CcSEcCtD
Droperidol—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.0023	0.0231	CcSEcCtD
Droperidol—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00226	0.0227	CcSEcCtD
Droperidol—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.00221	0.0222	CcSEcCtD
Droperidol—HTR2A—blood vessel—Alzheimer's disease	0.00172	0.0305	CbGeAlD
Droperidol—ADRA1A—forebrain—Alzheimer's disease	0.0014	0.0249	CbGeAlD
Droperidol—DRD2—forebrain—Alzheimer's disease	0.00137	0.0244	CbGeAlD
Droperidol—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00137	0.0138	CcSEcCtD
Droperidol—KCNH2—forebrain—Alzheimer's disease	0.00135	0.024	CbGeAlD
Droperidol—Depression—Galantamine—Alzheimer's disease	0.00135	0.0136	CcSEcCtD
Droperidol—ADRA1A—telencephalon—Alzheimer's disease	0.00129	0.0229	CbGeAlD
Droperidol—DRD2—telencephalon—Alzheimer's disease	0.00126	0.0224	CbGeAlD
Droperidol—KCNH2—telencephalon—Alzheimer's disease	0.00124	0.0221	CbGeAlD
Droperidol—Hallucination—Galantamine—Alzheimer's disease	0.00121	0.0121	CcSEcCtD
Droperidol—Cardiac arrest—Memantine—Alzheimer's disease	0.00118	0.0118	CcSEcCtD
Droperidol—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00115	0.0115	CcSEcCtD
Droperidol—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00106	0.0107	CcSEcCtD
Droperidol—Bronchospasm—Memantine—Alzheimer's disease	0.00105	0.0106	CcSEcCtD
Droperidol—Depression—Donepezil—Alzheimer's disease	0.00105	0.0105	CcSEcCtD
Droperidol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00103	0.0103	CcSEcCtD
Droperidol—HTR2A—embryo—Alzheimer's disease	0.00102	0.0182	CbGeAlD
Droperidol—Hyperglycaemia—Memantine—Alzheimer's disease	0.000964	0.00968	CcSEcCtD
Droperidol—Depression—Memantine—Alzheimer's disease	0.00095	0.00954	CcSEcCtD
Droperidol—Syncope—Galantamine—Alzheimer's disease	0.000949	0.00953	CcSEcCtD
Droperidol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000943	0.00947	CcSEcCtD
Droperidol—Hallucination—Donepezil—Alzheimer's disease	0.000937	0.00941	CcSEcCtD
Droperidol—Palpitations—Galantamine—Alzheimer's disease	0.000935	0.00939	CcSEcCtD
Droperidol—Drowsiness—Rivastigmine—Alzheimer's disease	0.000932	0.00936	CcSEcCtD
Droperidol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00093	0.00934	CcSEcCtD
Droperidol—Depression—Rivastigmine—Alzheimer's disease	0.000929	0.00933	CcSEcCtD
Droperidol—Hypertension—Galantamine—Alzheimer's disease	0.000914	0.00917	CcSEcCtD
Droperidol—HTR2A—forebrain—Alzheimer's disease	0.000906	0.0161	CbGeAlD
Droperidol—Anxiety—Galantamine—Alzheimer's disease	0.000898	0.00901	CcSEcCtD
Droperidol—Pimozide—CALM1—Alzheimer's disease	0.000875	0.167	CrCbGaD
Droperidol—Hallucination—Memantine—Alzheimer's disease	0.000851	0.00854	CcSEcCtD
Droperidol—Shock—Galantamine—Alzheimer's disease	0.00085	0.00853	CcSEcCtD
Droperidol—Chills—Donepezil—Alzheimer's disease	0.000845	0.00849	CcSEcCtD
Droperidol—Tachycardia—Galantamine—Alzheimer's disease	0.000843	0.00846	CcSEcCtD
Droperidol—HTR2A—telencephalon—Alzheimer's disease	0.000833	0.0148	CbGeAlD
Droperidol—Hallucination—Rivastigmine—Alzheimer's disease	0.000833	0.00836	CcSEcCtD
Droperidol—Hypotension—Galantamine—Alzheimer's disease	0.000807	0.0081	CcSEcCtD
Droperidol—Pimozide—HTR6—Alzheimer's disease	0.00079	0.151	CrCbGaD
Droperidol—Haloperidol—GRIN2B—Alzheimer's disease	0.000781	0.149	CrCbGaD
Droperidol—Somnolence—Galantamine—Alzheimer's disease	0.000768	0.00771	CcSEcCtD
Droperidol—Chills—Memantine—Alzheimer's disease	0.000768	0.0077	CcSEcCtD
Droperidol—ADRA1A—nervous system—Alzheimer's disease	0.000761	0.0135	CbGeAlD
Droperidol—Chills—Rivastigmine—Alzheimer's disease	0.000751	0.00754	CcSEcCtD
Droperidol—DRD2—nervous system—Alzheimer's disease	0.000746	0.0133	CbGeAlD
Droperidol—Syncope—Donepezil—Alzheimer's disease	0.000735	0.00738	CcSEcCtD
Droperidol—KCNH2—nervous system—Alzheimer's disease	0.000735	0.0131	CbGeAlD
Droperidol—ADRA1A—central nervous system—Alzheimer's disease	0.000733	0.013	CbGeAlD
Droperidol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000721	0.00724	CcSEcCtD
Droperidol—DRD2—central nervous system—Alzheimer's disease	0.000718	0.0128	CbGeAlD
Droperidol—ADRA1A—cerebellum—Alzheimer's disease	0.000716	0.0127	CbGeAlD
Droperidol—Hypertension—Donepezil—Alzheimer's disease	0.000708	0.00711	CcSEcCtD
Droperidol—KCNH2—central nervous system—Alzheimer's disease	0.000707	0.0126	CbGeAlD
Droperidol—DRD2—cerebellum—Alzheimer's disease	0.000702	0.0125	CbGeAlD
Droperidol—Anxiety—Donepezil—Alzheimer's disease	0.000696	0.00698	CcSEcCtD
Droperidol—KCNH2—cerebellum—Alzheimer's disease	0.000691	0.0123	CbGeAlD
Droperidol—Body temperature increased—Galantamine—Alzheimer's disease	0.000683	0.00685	CcSEcCtD
Droperidol—Syncope—Memantine—Alzheimer's disease	0.000668	0.0067	CcSEcCtD
Droperidol—Shock—Donepezil—Alzheimer's disease	0.000659	0.00661	CcSEcCtD
Droperidol—Palpitations—Memantine—Alzheimer's disease	0.000658	0.00661	CcSEcCtD
Droperidol—Loss of consciousness—Memantine—Alzheimer's disease	0.000654	0.00657	CcSEcCtD
Droperidol—Syncope—Rivastigmine—Alzheimer's disease	0.000653	0.00656	CcSEcCtD
Droperidol—Palpitations—Rivastigmine—Alzheimer's disease	0.000644	0.00646	CcSEcCtD
Droperidol—Hypertension—Memantine—Alzheimer's disease	0.000643	0.00645	CcSEcCtD
Droperidol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00064	0.00643	CcSEcCtD
Droperidol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000636	0.00639	CcSEcCtD
Droperidol—Anxiety—Memantine—Alzheimer's disease	0.000632	0.00634	CcSEcCtD
Droperidol—Hypertension—Rivastigmine—Alzheimer's disease	0.000629	0.00631	CcSEcCtD
Droperidol—Hypotension—Donepezil—Alzheimer's disease	0.000625	0.00628	CcSEcCtD
Droperidol—Anxiety—Rivastigmine—Alzheimer's disease	0.000618	0.0062	CcSEcCtD
Droperidol—Fenbufen—PTGS1—Alzheimer's disease	0.000615	0.118	CrCbGaD
Droperidol—Shock—Memantine—Alzheimer's disease	0.000598	0.006	CcSEcCtD
Droperidol—Somnolence—Donepezil—Alzheimer's disease	0.000595	0.00597	CcSEcCtD
Droperidol—Tachycardia—Memantine—Alzheimer's disease	0.000593	0.00595	CcSEcCtD
Droperidol—Shock—Rivastigmine—Alzheimer's disease	0.000585	0.00587	CcSEcCtD
Droperidol—ADRA1A—brain—Alzheimer's disease	0.000582	0.0103	CbGeAlD
Droperidol—Tachycardia—Rivastigmine—Alzheimer's disease	0.00058	0.00582	CcSEcCtD
Droperidol—Dizziness—Galantamine—Alzheimer's disease	0.000571	0.00573	CcSEcCtD
Droperidol—DRD2—brain—Alzheimer's disease	0.00057	0.0101	CbGeAlD
Droperidol—Hypotension—Memantine—Alzheimer's disease	0.000568	0.0057	CcSEcCtD
Droperidol—KCNH2—brain—Alzheimer's disease	0.000562	0.00998	CbGeAlD
Droperidol—Hypotension—Rivastigmine—Alzheimer's disease	0.000556	0.00558	CcSEcCtD
Droperidol—Rash—Galantamine—Alzheimer's disease	0.000545	0.00547	CcSEcCtD
Droperidol—Dermatitis—Galantamine—Alzheimer's disease	0.000544	0.00546	CcSEcCtD
Droperidol—Somnolence—Memantine—Alzheimer's disease	0.00054	0.00542	CcSEcCtD
Droperidol—Body temperature increased—Donepezil—Alzheimer's disease	0.000529	0.00531	CcSEcCtD
Droperidol—Somnolence—Rivastigmine—Alzheimer's disease	0.000529	0.00531	CcSEcCtD
Droperidol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000493	0.00495	CcSEcCtD
Droperidol—HTR2A—nervous system—Alzheimer's disease	0.000492	0.00874	CbGeAlD
Droperidol—Body temperature increased—Memantine—Alzheimer's disease	0.00048	0.00482	CcSEcCtD
Droperidol—HTR2A—central nervous system—Alzheimer's disease	0.000474	0.00841	CbGeAlD
Droperidol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00047	0.00472	CcSEcCtD
Droperidol—HTR2A—cerebellum—Alzheimer's disease	0.000463	0.00822	CbGeAlD
Droperidol—Hypersensitivity—Memantine—Alzheimer's disease	0.000448	0.00449	CcSEcCtD
Droperidol—Dizziness—Donepezil—Alzheimer's disease	0.000443	0.00444	CcSEcCtD
Droperidol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000438	0.0044	CcSEcCtD
Droperidol—Rash—Donepezil—Alzheimer's disease	0.000422	0.00424	CcSEcCtD
Droperidol—Dermatitis—Donepezil—Alzheimer's disease	0.000422	0.00423	CcSEcCtD
Droperidol—Fluspirilene—SLC6A4—Alzheimer's disease	0.000404	0.0773	CrCbGaD
Droperidol—Dizziness—Memantine—Alzheimer's disease	0.000402	0.00403	CcSEcCtD
Droperidol—Dizziness—Rivastigmine—Alzheimer's disease	0.000393	0.00395	CcSEcCtD
Droperidol—Rash—Memantine—Alzheimer's disease	0.000383	0.00385	CcSEcCtD
Droperidol—Dermatitis—Memantine—Alzheimer's disease	0.000383	0.00384	CcSEcCtD
Droperidol—HTR2A—brain—Alzheimer's disease	0.000376	0.00668	CbGeAlD
Droperidol—Rash—Rivastigmine—Alzheimer's disease	0.000375	0.00376	CcSEcCtD
Droperidol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000375	0.00376	CcSEcCtD
Droperidol—Fenbufen—PTGS2—Alzheimer's disease	0.000352	0.0672	CrCbGaD
Droperidol—Fluspirilene—HTR2A—Alzheimer's disease	0.000311	0.0594	CrCbGaD
Droperidol—Domperidone—CYP2D6—Alzheimer's disease	0.000254	0.0486	CrCbGaD
Droperidol—Pimozide—HTR2A—Alzheimer's disease	0.000232	0.0444	CrCbGaD
Droperidol—Pimozide—CYP2D6—Alzheimer's disease	0.000212	0.0406	CrCbGaD
Droperidol—Haloperidol—HTR2A—Alzheimer's disease	0.000212	0.0405	CrCbGaD
Droperidol—Haloperidol—CYP2D6—Alzheimer's disease	0.000194	0.0371	CrCbGaD
Droperidol—DRD2—Signaling by GPCR—NPY—Alzheimer's disease	2.4e-05	0.000813	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IAPP—Alzheimer's disease	2.38e-05	0.000808	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—NPS—Alzheimer's disease	2.38e-05	0.000806	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—NPY—Alzheimer's disease	2.36e-05	0.0008	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IAPP—Alzheimer's disease	2.34e-05	0.000795	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—NPS—Alzheimer's disease	2.33e-05	0.000789	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CRH—Alzheimer's disease	2.31e-05	0.000784	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—NPY—Alzheimer's disease	2.31e-05	0.000783	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—SST—Alzheimer's disease	2.3e-05	0.000781	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.3e-05	0.000781	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IAPP—Alzheimer's disease	2.3e-05	0.000779	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CRH—Alzheimer's disease	2.28e-05	0.000772	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GAB2—Alzheimer's disease	2.27e-05	0.000769	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—SST—Alzheimer's disease	2.27e-05	0.000769	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDK5—Alzheimer's disease	2.26e-05	0.000765	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—F2—Alzheimer's disease	2.25e-05	0.000764	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—APP—Alzheimer's disease	2.24e-05	0.000761	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CRH—Alzheimer's disease	2.23e-05	0.000756	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GAB2—Alzheimer's disease	2.22e-05	0.000753	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—SST—Alzheimer's disease	2.22e-05	0.000753	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDK5—Alzheimer's disease	2.22e-05	0.000753	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—F2—Alzheimer's disease	2.22e-05	0.000752	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—APP—Alzheimer's disease	2.21e-05	0.000749	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—NPS—Alzheimer's disease	2.19e-05	0.000744	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.18e-05	0.00074	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDK5—Alzheimer's disease	2.17e-05	0.000737	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—F2—Alzheimer's disease	2.17e-05	0.000736	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR6—Alzheimer's disease	2.17e-05	0.000736	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—APP—Alzheimer's disease	2.16e-05	0.000734	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—NPS—Alzheimer's disease	2.16e-05	0.000732	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.15e-05	0.000728	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR6—Alzheimer's disease	2.14e-05	0.000724	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.12e-05	0.000718	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—NPS—Alzheimer's disease	2.11e-05	0.000716	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.1e-05	0.000713	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GAB2—Alzheimer's disease	2.09e-05	0.000709	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—SST—Alzheimer's disease	2.09e-05	0.000709	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	2.09e-05	0.000709	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.08e-05	0.000707	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—SST—Alzheimer's disease	2.06e-05	0.000698	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GAB2—Alzheimer's disease	2.06e-05	0.000698	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.04e-05	0.000692	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—APP—Alzheimer's disease	2.04e-05	0.000691	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	2.02e-05	0.000684	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	2.02e-05	0.000684	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.01e-05	0.000682	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCL2—Alzheimer's disease	2.01e-05	0.000681	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—APP—Alzheimer's disease	2.01e-05	0.00068	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCL2—Alzheimer's disease	1.98e-05	0.00067	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PSENEN—Alzheimer's disease	1.97e-05	0.000669	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	1.96e-05	0.000666	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APH1A—Alzheimer's disease	1.94e-05	0.000659	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PSENEN—Alzheimer's disease	1.94e-05	0.000658	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	1.94e-05	0.000656	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.92e-05	0.000652	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APH1A—Alzheimer's disease	1.91e-05	0.000649	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	1.9e-05	0.000644	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NCSTN—Alzheimer's disease	1.89e-05	0.000642	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.89e-05	0.000642	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	1.87e-05	0.000635	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NCSTN—Alzheimer's disease	1.86e-05	0.000632	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.85e-05	0.000629	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LRP1—Alzheimer's disease	1.85e-05	0.000626	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—TP53—Alzheimer's disease	1.82e-05	0.000619	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	1.82e-05	0.000618	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LRP1—Alzheimer's disease	1.82e-05	0.000616	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GAL—Alzheimer's disease	1.8e-05	0.000611	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GFAP—Alzheimer's disease	1.8e-05	0.000611	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	1.78e-05	0.000603	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GAL—Alzheimer's disease	1.77e-05	0.000602	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GFAP—Alzheimer's disease	1.77e-05	0.000602	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	1.74e-05	0.000589	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	1.74e-05	0.000589	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—Alzheimer's disease	1.67e-05	0.000566	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—A2M—Alzheimer's disease	1.59e-05	0.000539	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.57e-05	0.000531	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—A2M—Alzheimer's disease	1.56e-05	0.00053	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.56e-05	0.000528	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.54e-05	0.000523	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PSEN2—Alzheimer's disease	1.54e-05	0.000522	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	1.53e-05	0.000519	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.52e-05	0.000517	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PSEN2—Alzheimer's disease	1.51e-05	0.000514	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.51e-05	0.000512	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.48e-05	0.000503	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	1.48e-05	0.000503	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.46e-05	0.000495	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.45e-05	0.000493	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.43e-05	0.000485	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.42e-05	0.000482	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NPY—Alzheimer's disease	1.42e-05	0.00048	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IAPP—Alzheimer's disease	1.41e-05	0.000477	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.4e-05	0.000475	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.4e-05	0.000475	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NPY—Alzheimer's disease	1.39e-05	0.000473	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IAPP—Alzheimer's disease	1.38e-05	0.00047	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.37e-05	0.000465	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CRH—Alzheimer's disease	1.37e-05	0.000463	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	1.36e-05	0.000463	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	1.36e-05	0.00046	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR5—Alzheimer's disease	1.35e-05	0.000457	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CRH—Alzheimer's disease	1.34e-05	0.000456	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR5—Alzheimer's disease	1.33e-05	0.00045	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.32e-05	0.000447	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	1.32e-05	0.000446	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	1.3e-05	0.00044	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NPS—Alzheimer's disease	1.3e-05	0.000439	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.29e-05	0.000437	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NPS—Alzheimer's disease	1.27e-05	0.000432	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	1.27e-05	0.000432	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.27e-05	0.000431	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	1.27e-05	0.000431	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.27e-05	0.00043	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—F2—Alzheimer's disease	1.25e-05	0.000425	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.25e-05	0.000424	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	1.25e-05	0.000423	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.24e-05	0.000421	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	1.24e-05	0.000419	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SST—Alzheimer's disease	1.24e-05	0.000419	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	1.24e-05	0.000419	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	1.23e-05	0.000417	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	1.23e-05	0.000416	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	1.22e-05	0.000415	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	1.22e-05	0.000415	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GAB2—Alzheimer's disease	1.22e-05	0.000412	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SST—Alzheimer's disease	1.22e-05	0.000412	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.22e-05	0.000412	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.21e-05	0.000411	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.21e-05	0.000409	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APP—Alzheimer's disease	1.2e-05	0.000408	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	1.19e-05	0.000404	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	1.19e-05	0.000404	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	1.19e-05	0.000404	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	1.19e-05	0.000402	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APP—Alzheimer's disease	1.18e-05	0.000402	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	1.18e-05	0.0004	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	1.16e-05	0.000393	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—F2—Alzheimer's disease	1.16e-05	0.000392	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	1.14e-05	0.000386	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	1.14e-05	0.000385	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.12e-05	0.000379	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	1.11e-05	0.000378	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.09e-05	0.000371	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	1.06e-05	0.00036	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	1.05e-05	0.000357	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	1.04e-05	0.000354	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.04e-05	0.000352	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	1.04e-05	0.000351	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	1.03e-05	0.00035	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	1.02e-05	0.000346	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.02e-05	0.000346	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.01e-05	0.000344	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.01e-05	0.000344	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	9.98e-06	0.000338	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	9.93e-06	0.000337	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—S100B—Alzheimer's disease	9.79e-06	0.000332	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	9.63e-06	0.000327	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	9.43e-06	0.00032	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	9.32e-06	0.000316	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	9.17e-06	0.000311	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	9.01e-06	0.000306	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	8.98e-06	0.000305	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	8.87e-06	0.000301	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	8.68e-06	0.000295	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LPL—Alzheimer's disease	8.64e-06	0.000293	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	8.56e-06	0.00029	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	8.5e-06	0.000288	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	8.43e-06	0.000286	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	8.4e-06	0.000285	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	8.33e-06	0.000282	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	8.27e-06	0.00028	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	8.25e-06	0.00028	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGF—Alzheimer's disease	8.19e-06	0.000278	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	8.1e-06	0.000275	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	8.05e-06	0.000273	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	7.96e-06	0.00027	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	7.89e-06	0.000267	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	7.83e-06	0.000266	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	7.79e-06	0.000264	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	7.67e-06	0.00026	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	7.51e-06	0.000255	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	7.27e-06	0.000247	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—Alzheimer's disease	7.24e-06	0.000246	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—Alzheimer's disease	7.24e-06	0.000246	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	7.18e-06	0.000243	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	7.15e-06	0.000243	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	7.13e-06	0.000242	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	7.13e-06	0.000242	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	7.06e-06	0.00024	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	7e-06	0.000238	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	6.98e-06	0.000237	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	6.98e-06	0.000237	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	6.92e-06	0.000235	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	6.92e-06	0.000235	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—F2—Alzheimer's disease	6.83e-06	0.000232	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	6.81e-06	0.000231	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—F2—Alzheimer's disease	6.72e-06	0.000228	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.69e-06	0.000227	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	6.66e-06	0.000226	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	6.58e-06	0.000223	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.58e-06	0.000223	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.44e-06	0.000218	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	6.27e-06	0.000213	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	6.22e-06	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—Alzheimer's disease	6.19e-06	0.00021	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	6.17e-06	0.000209	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	6.12e-06	0.000208	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—Alzheimer's disease	6.09e-06	0.000207	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	6.09e-06	0.000207	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.04e-06	0.000205	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	6e-06	0.000203	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	5.99e-06	0.000203	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	5.99e-06	0.000203	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	5.96e-06	0.000202	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	5.89e-06	0.0002	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	5.87e-06	0.000199	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	5.77e-06	0.000196	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	5.43e-06	0.000184	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	5.34e-06	0.000181	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	5.23e-06	0.000177	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.65e-06	0.000158	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	4.61e-06	0.000156	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	4.58e-06	0.000155	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.58e-06	0.000155	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	4.53e-06	0.000154	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	4.5e-06	0.000153	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.48e-06	0.000152	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	4.44e-06	0.000151	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	4.41e-06	0.00015	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	4.23e-06	0.000144	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	4.22e-06	0.000143	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	4.17e-06	0.000141	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	4.16e-06	0.000141	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.08e-06	0.000138	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.07e-06	0.000138	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.91e-06	0.000133	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.85e-06	0.00013	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.77e-06	0.000128	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	3.59e-06	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	3.53e-06	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.46e-06	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.95e-06	0.0001	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	2.91e-06	9.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2.85e-06	9.65e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.7e-06	9.17e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	2.66e-06	9.02e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.61e-06	8.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.49e-06	8.46e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	2.45e-06	8.33e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	2.4e-06	8.15e-05	CbGpPWpGaD
